Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
11/2003
11/20/2003US20030216391 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
11/20/2003US20030216330 Especially for methicillin or vancomycin resistant Staphylococcus aureus, vancomycin resistant Enterococci or glycopeptide-intermediate Staphylococcus aureus
11/20/2003US20030215667 Electroluminescent devices
11/19/2003EP1362849A2 Process for production of piperidine derivatives
11/19/2003EP1362848A1 Process for the preparation of vitamin D derivatives
11/19/2003EP1362040A2 Process for the preparation of mesylates of piperazine derivatives
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/18/2003US6649645 Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
11/18/2003US6649641 Glucagon antagonists/inverse agonists
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/13/2003WO2003093254A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003WO2003093247A2 Antibacterial agents
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2003092852A1 Crystallization system utilizing atomization
11/13/2003WO2003092374A2 Pesticidal heterocycles
11/13/2003WO2003082864A3 Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
11/13/2003WO2003029200A3 Compounds useful as reversible inhibitors of cysteine proteases
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2002040020A9 Novel use of certain insulin sensitizers or ppar-gamma agonists
11/13/2003WO2002032874A8 Substituted heterocyclic compounds for treating multidrug resistance
11/13/2003WO2002032868A8 2-substituted heterocyclic compounds and their use in treating multidrug resistance
11/13/2003WO2002016327A8 Benzimidazoles and analogues and their use as neutrophil inhibitors
11/13/2003US20030212116 Contorlling plant disease
11/13/2003US20030212067 Bone disorders; rheumatic diseases; wound healing agents
11/13/2003US20030212063 beta3 adrenergic receptor agonists
11/13/2003CA2485065A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003CA2484212A1 Crystallization system utilizing atomization
11/13/2003CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/12/2003EP1360179A2 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione or hydantoin
11/12/2003EP0996618B1 Endothelin antagonists: n- 2'- (4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl) 1,1'-biphenyl]-2-yl]methyl] -n,3,3-trimethylbutanamide and n-(4,5-dimethyl-3-isoxazolyl) -2'- (3,3-dimethyl-2-oxo-1-pyrrolidinyl) methyl] -4'-(2-oxazolyl) 1,1'-biphenyl]-2-sulfonamide and salts thereof
11/12/2003EP0880509B1 2,4-diamino-1,3,5-triazines, processes for their preparation and their use as herbicides and plant-growth regulators
11/11/2003US6646243 Fixing biopolymers to substrate; obtain substrate, incubate with nucleotide sequences, expose to activator, recover product
11/11/2003US6646009 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/11/2003US6645993 3-heterocyclylpropanohydroxamic acid PCP inhibitors
11/11/2003US6645939 Substituted β-alanine derivatives as cell adhesion inhibitors
11/06/2003WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient
11/06/2003WO2003090680A2 Novel phenyl derivatives as inducers of apoptosis
11/06/2003WO2002056013A3 Oxazolidinone photoaffinity probes, uses and compounds
11/06/2003WO2002051983A3 Novel compounds and compositions as cathepsin inhibitors
11/06/2003US20030207919 For treating, preventing, reducing inflammation, pain, fever,gastrointestinal disorders; decreasing gastrointestinal, renal and other toxicities resulting from use of nonsteroidal antiinflammatory drugs; multiplicity of compounds
11/06/2003US20030207895 Tissue factor antagonists and methods of use thereof
11/06/2003US20030207786 Novel heterocyclic pro- fragrances, preferably oxazolidines, tertahydro-1,3-oxazines, thiazolidines, or tetrahydro-1,3-thiazines, more preferably oxazolidines, or tertahydro-1,3-oxazines, most preferably oxazolidines, which
11/05/2003EP1358167A1 Novel 2-benzoxazolyl benzene derivatives and their use as uv screening agents
11/05/2003EP1358144A1 Epothilone synthesis components iii and iv: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone b, d and epothilone derivatives
11/05/2003EP1054857B1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/04/2003US6642389 Oxazole derivatives
11/04/2003US6642379 Containing oxazolyl, thiazolyl or imidazolyl groups
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003US6642238 Microbiocides against grampositive and gramnegative bacteria
11/04/2003US6642218 (5Z,7E,22E)-(1S,3R,24R)-25-(5-Propyloxazol-2-yl)-26,27-cyclo -9,10-secocholesta-5,7,10(19), 22-tetraene-1,3,24-triol for treatment of diseases characterized by hyperproliferation and deficient cell differentiation
10/2003
10/30/2003WO2003089418A1 Indane acetic acid derivatives and their use as pharmaceutical agents
10/30/2003WO2003088959A2 Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/30/2003WO2003044877A3 Light emitting device and compounds for use therein
10/30/2003WO2003018762A3 Compositions that bind antiterminator rna and their assays
10/30/2003US20030204096 Enantioselective synthesis of azetidinone intermediate compounds
10/30/2003US20030203947 Activator of PPAR delta
10/30/2003US20030203946 Glucagon antagonists/inverse agonists
10/30/2003US20030203913 Beta3 adrenergic receptor agonists and uses thereof
10/30/2003CA2482714A1 Indane acetic acid derivatives and their use as pharmaceutical agents
10/30/2003CA2482510A1 Monotherapy for the treatment of parkinson`s disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/29/2003EP1357115A1 Alkanoic acid derivatives, process for their production and use thereof
10/29/2003EP1355879A1 Carboxamides as fungicides in agriculture
10/28/2003US6639074 Reacting an alpha -substituted ketone with a cyclic alkylenetetramine in solvent(s) to form a quaternary ammonium salt; reacting with acid in solvent(s) form an alpha -amino ketone; reacting with acyl derivative; dehydrating
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638563 Comprises dimethyacrylamide-octafluoropentylmethacrylate-glycidyl methacrylate for enhancing biocompatibility/ hydrophilicity of surfaces of silicone contact lenses (overnight and continuous wear) and medical implants
10/28/2003CA2233792C Process to chloroketones using oxazolines
10/23/2003WO2003087077A1 A semi-synthetic process for the preparation of n­ debenzoylpaclitaxel
10/23/2003WO2003087068A1 Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses
10/23/2003WO2003087062A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003086287A2 Compounds and methods for inducing apoptosis in proliferating cells
10/23/2003US20030199564 Indane derivatives
10/23/2003US20030199563 Heterocyclic containing biphenyl aP2 inhibitors and method
10/23/2003US20030199562 Substituted benzoxazoles as estrogenic agents
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003US20030199479 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/23/2003CA2485679A1 Compounds and methods for inducing apoptosis in proliferating cells
10/23/2003CA2482207A1 Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses
10/23/2003CA2480856A1 Substituted aryl amides
10/22/2003EP1354879A1 Dihydronaphthalene derivative compounds and drugs containing these compounds as the active ingredient
10/22/2003EP1353911A1 Antiviral agents
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003CN1450051A Amino acid derivatives and their use as pesticides
10/22/2003CN1125044C Novel prostaglandin synthase inhibitors
10/21/2003US6635784 Process for the preparation of enantiomerically-enriched cyclopropylalanine derivates
10/21/2003US6635769 Oxazolidinone is reacted with electrophile selected from alkyl bromide or iodide; reaction mixture comprising aprotic and nonoxidizing solvent and potassium fluoride on alumina; without a substantial amount of strong base
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635364 Aromatic condensed-ring compound, light emitting device material and light emitting device using the same
10/21/2003CA2240136C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
10/21/2003CA2213737C 2-arylbenzazole compounds
10/21/2003CA2003480C Fungicides
10/16/2003WO2003084964A1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003084919A2 Method for preparing combretastatins
10/16/2003WO2003084915A1 Novel thyroid receptor ligands
10/16/2003WO2003084535A1 Antidiabetic agents
10/16/2003WO2003084534A1 Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
1 ... 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 ... 210